Barriers to enrollment in a randomized controlled trial of hydrocortisone for cardiovascular insufficiency in term and late preterm newborn infants

OBJECTIVE: To analyze reasons for low enrollment in an RCT of the effect of hydrocortisone for cardiovascular insufficiency on survival without neurodevelopmental impairment (NDI) in term/late-preterm newborns. STUDY DESIGN: The original study was a multicenter RCT. Eligibility: ≥34 weeks’ gestation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Perinatol
Main Authors: Watterberg, Kristi L., Fernandez, Erika, Walsh, Michele C., Truog, William E., Stoll, Barbara J., Sokol, Gregory M., Kennedy, Kathleen A., Fraga, Maria V., Beauman, Sandra Sundquist, Carper, Benjamin, Das, Abhik, Duncan, Andrea Freeman, Buss, William F., Gauldin, Cheri, Lacy, Conra Backstrom, Sanchez, Pablo J., Chawla, Sanjay, Lakshminrusimha, Satyan, Cotten, C. Michael, Van Meurs, Krisa P., Poindexter, Brenda B., Bell, Edward F., Carlo, Waldemar A., Devaskar, Uday, Wyckoff, Myra H., Higgins, Rosemary D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688018/
https://ncbi.nlm.nih.gov/pubmed/28880260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jp.2017.131
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados